Your browser doesn't support javascript.
loading
Peritoneal dialysis-related peritonitis caused by Gordonia bronchialis: first pediatric report.
Bruno, Valentina; Tjon, James; Lin, Sandy; Groves, Helen; Kazmi, Kescha; Zappitelli, Michael; Harvey, Elizabeth.
Afiliação
  • Bruno V; Division of Nephrology, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada. valentina.bruno@sickkids.ca.
  • Tjon J; Department of Paediatrics, University of Toronto, Toronto, ON, Canada. valentina.bruno@sickkids.ca.
  • Lin S; Department of Pharmacy, The Hospital for Sick Children, Toronto, ON, Canada.
  • Groves H; Department of Nursing, The Hospital for Sick Children, Toronto, ON, Canada.
  • Kazmi K; Department of Paediatrics, University of Toronto, Toronto, ON, Canada.
  • Zappitelli M; Division of Infectious Diseases, The Hospital for Sick Children, Toronto, ON, Canada.
  • Harvey E; Department of Paediatrics, University of Toronto, Toronto, ON, Canada.
Pediatr Nephrol ; 37(1): 217-220, 2022 01.
Article em En | MEDLINE | ID: mdl-34633526
ABSTRACT

INTRODUCTION:

Gordonia species, aerobic, weakly acid-fast, Gram-positive bacilli, are a rare cause of peritonitis in patients undergoing peritoneal dialysis (PD). We report the first pediatric case of PD-related peritonitis caused by Gordonia bronchialis. CASE PRESENTATION A 13-year-old girl with chronic kidney disease (CKD) stage 5D, on continuous cycling PD (CCPD) for 8 years, presented with cloudy PD effluent, with no abdominal discomfort or fever. Intra-peritoneal (IP) loading doses of vancomycin and ceftazidime were started at home after obtaining a PD effluent sample, which showed WBC 2,340 × 10 /L (59% neutrophils) and Gram-positive bacilli. On admission, she was clinically well and afebrile, with no history of methicillin-resistant Staphylococcus aureus (MRSA) infection, so vancomycin was discontinued, and IP ceftazidime and cefazolin were started, following a loading dose of intravenous cefazolin. Gordonia species grew after 5 days of incubation and later identified as Gordonia bronchialis. IP vancomycin was restarted as monotherapy, empirically for a total of 3 weeks therapy. A 2-week course of oral ciprofloxacin was added, based on susceptibility testing. PD catheter replacement was advised due to the risk of recurrence but was refused. A relapse occurred 16 days after discontinuing antibiotics, successfully treated with a 2-week course of IP ceftazidime and vancomycin. The PD catheter was removed and hemodialysis initiated. She received a further 2-week course of oral ciprofloxacin and amoxicillin-clavulanate post PD catheter removal.

CONCLUSIONS:

Gordonia bronchialis is an emerging pathogen in PD peritonitis and appears to be associated with a high risk of relapse. PD catheter replacement is strongly suggested.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Adolescent / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Adolescent / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article